This Brief focuses on the cancer therapy available till date, from conventional drug delivery to nanomedicine in clinical trial. In addition, it reports on future generation based nanotherapeutics and cancer theranostic agent for effective therapeutic diagnosis and treatment. Breast cancer was chosen as the model system in this review. The authors give emphasis to multiple drug resistance (MDR) and its mechanism and how to overcome it using the nanoparticle approach.
Preface.- Introduction. "The book is informative for graduate students interested in the field of cancer therapy, for researchers working in the medical and biological sciences and for any scientists who are interested in nanomedicine. It represents very helpful small book providing an overview of conventional cancer therapies comparing them to nanomedicine based modern-day tumor therapy. It should not be missed in all biomedical research laboratories interested in modern approaches to cancer therapy." (Cestmir Altaner, Neoplasma, Vol. 64 (2), 2017)
